Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Placebo-controlled Trial of Olanzapine Versus Aprepitant Plus Ondansetron and Dexamethasone as Antiemetic Prophylaxis in Patients Receiving High Emetic Chemotherapy

NCT03876938 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT03876938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03876938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Placebo-controlled Trial of Olanzapine Versus Aprepitant Plus Ondansetron and Dexamethasone as Antiemetic Prophylaxis in Patients Receiving High Emetic Chemotherapy
Lead sponsor
Mahidol University
Phase
Phase 3
Overall status
Unknown status
Start date
March 1, 2019
Completion date
December 31, 2020
Enrollment
147 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

antiemetic for highly emetogenic chemotherapy